Ad Code: 34941

For patients with moderate to severe plaque psoriasis, bimekizumab was well tolerated, according to a study published in JAMA Dermatology. Kenneth B. Gordon, MD, and colleagues evaluated the 2-year safety profile of bimekizumab...

A diffuse reflectance spectroscopy (DRS) method can quantify skin barrier function and hemoglobin concentration, thereby improving severity evaluation in psoriasis vulgaris, according to a study pulished in Scientific Reports....

Psoriasis was associated with nonalcoholic fatty liver disease (NAFLD) in a US outpatient population, according to a study published in JAMA Dermatology. Researchers used data from an outpatient sample of 5,672 US adults (aged...